サルタンの世界市場レポート 2025

サルタンの市場規模は、今後数年間で安定した成長が見込まれます。2029年の年間平均成長率（CAGR）は4.5%で、266億6,000万米ドルに成長します。予測される成長の要因としては、併用療法への注目の高まり、医薬品研究開発への投資の増加、新興市場における需要の高まり、ヘルスケアインフラの拡充、生活習慣病の蔓延などが挙げられます。この期間に予想される主な動向としては、ドラッグデリバリー技術の発展、原薬の高度な製造プロセスの開発、合剤の創出、個別化高血圧治療におけるイノベーション、新規サルタン誘導体の開発などが挙げられます。

高血圧の有病率の上昇は、サルタン市場の成長を促進すると予想されます。持続的な高血圧を特徴とする高血圧症は、心臓病、脳卒中、その他の深刻な健康合併症のリスクを高める。高血圧の増加には、塩分や加工食品の多い食生活が大きく関係しており、体液の貯留や心臓への負担が増加します。サルタンは、血管を収縮させるホルモンであるアンジオテンシンIIをブロックすることで、高血圧の管理を助ける。血管を弛緩させ広げることにより、サルタンは血圧を下げ、心臓の仕事量を減らします。例えば、2024年1月、米国心臓協会は、2022年の高血圧による死亡者数は13万1,454人で、2021年の12万4,508人から増加したと報告しました。その結果、高血圧の有病率の上昇がサルタン市場の成長を促進しています。

サルタン市場の主要企業は、治療効果と患者のアドヒアランスを向上させるため、錠剤型サルタンなどの新興国製品の開発に注力しています。これらの内服薬には、アンジオテンシンIIの作用を阻害し、血管の弛緩を促進して血圧を低下させるサルタン製剤が含まれています。例えば、2024年7月、インドの製薬会社ザイダス・ライフサイエンシズ社は、ディオバンという商品名で販売されているバルサルタン錠USP（40mg、80mg）の米国食品医薬品局（FDA）の承認を取得しました。この錠剤は、成人の高血圧症、心不全の治療、心臓発作後の生存率の改善に処方され、1歳以上の小児患者にも適しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界サルタンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のサルタン市場：成長率分析
• 世界のサルタン市場の実績：規模と成長, 2019-2024
• 世界のサルタン市場の予測：規模と成長, 2024-2029, 2034F
• 世界サルタン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のサルタン市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バルサルタン
• テルミサルタン
• ロサルタン
• イルベサルタン
• アジルサルタン
• オルメサルタン
• 世界のサルタン市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のサルタン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高血圧
• 心血管疾患
• 腎臓病
• その他の用途
• 世界のサルタン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界のサルタン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のサルタン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• サルタン市場：競合情勢
• サルタン市場：企業プロファイル
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aurobindo Pharma Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Ltd.
• Cadila Pharmaceuticals Ltd.
• Lupin Ltd.
• Zydus Lifesciences Ltd.
• Torrent Pharmaceuticals Ltd.
• Alembic Pharmaceuticals Ltd.
• Vasudha Pharma Chem Ltd.
• Unichem Laboratories Ltd.
• Global Pharma Tek
• Manus Aktteva Biopharma LLP
• Emcure Pharmaceuticals Ltd.
• Wellona Pharma
• JPM Pharma & Chemicals Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• サルタン市場2029：新たな機会を提供する国
• サルタン市場2029：新たな機会を提供するセグメント
• サルタン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sartans, also known as angiotensin II receptor blockers (ARBs), are medications commonly prescribed to manage high blood pressure (hypertension) and heart failure. They work by blocking the action of angiotensin II, a hormone that constricts blood vessels, thereby promoting vessel relaxation, lowering blood pressure, and improving circulation. Sartans help reduce the risk of strokes, kidney damage, and heart attacks in individuals with specific cardiovascular conditions.

The main types of sartans include valsartan, telmisartan, losartan, irbesartan, azilsartan, and olmesartan. Valsartan, an angiotensin II receptor blocker (ARB), lowers blood pressure and reduces heart strain by relaxing blood vessels. It is distributed through various channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others. Valsartan is used for several applications, including hypertension, cardiovascular diseases, kidney diseases, and more, and is employed by various end-users such as hospitals, diagnostic laboratories, and others.

The sartans market research report is one of a series of new reports from The Business Research Company that provides sartans market statistics, including the sartans industry global market size, regional shares, competitors with the sartans market share, detailed sartans market segments, market trends, and opportunities, and any further data you may need to thrive in the sartans industry. This sartans market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sartans market size has grown steadily in recent years. It will grow from $21.36 billion in 2024 to $22.39 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth during the historic period can be attributed to factors such as the growing adoption of sedentary lifestyles, the increasing incidence of obesity, rising awareness about cardiovascular diseases, higher healthcare expenditure, and the rising demand for generic antihypertensive drugs.

The sartans market size is expected to see steady growth in the next few years. It will grow to $26.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The forecasted growth can be attributed to several factors, including a heightened focus on combination therapies, increased investments in pharmaceutical R&D, rising demand in emerging markets, expanded healthcare infrastructure, and the growing prevalence of lifestyle-related disorders. Key trends expected during this period include advancements in drug delivery technologies, the development of advanced manufacturing processes for APIs, the creation of fixed-dose combination drugs, innovations in personalized hypertension treatments, and the development of novel sartan derivatives.

The rising prevalence of hypertension is expected to drive the growth of the sartans market. Hypertension, a condition characterized by persistently high blood pressure, increases the risk of heart disease, stroke, and other serious health complications. The growing incidence of hypertension is largely linked to diets high in salt and processed foods, which can lead to fluid retention and added strain on the heart. Sartans help manage hypertension by blocking angiotensin II, a hormone that causes blood vessels to constrict. By relaxing and widening the blood vessels, sartans lower blood pressure and reduce the heart's workload. For example, in January 2024, the American Heart Association reported that high blood pressure was responsible for 131,454 deaths in 2022, an increase from 124,508 deaths in 2021. As a result, the rising prevalence of hypertension is driving the growth of the sartans market.

Leading companies in the sartans market are focusing on developing advanced products, such as tablet-form sartans, to improve treatment efficacy and patient adherence. These oral medications contain sartan drugs, which block the effects of angiotensin II, promoting blood vessel relaxation and lowering blood pressure. For example, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg), marketed under the brand name Diovan. These tablets are prescribed to treat hypertension, heart failure, and to improve survival after a heart attack in adults, and are also suitable for pediatric patients aged one year and older.

In April 2025, Scienture Holdings, Inc., a U.S.-based manufacturer of sartans, partnered with Saptalis Pharmaceuticals to develop and distribute Arbli (losartan potassium oral suspension, 10 mg/mL). This collaboration includes warehousing and distribution agreements with strategic partners to ensure market readiness for the first FDA-approved ready-to-use oral liquid losartan, addressing unmet needs in the treatment of hypertension. Saptalis Pharmaceuticals is a U.S.-based pharmaceutical company.

Major players in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sartans report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sartans market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sartans market consists of sales of candesartan, eprosartan, and fimasartan. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sartans Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sartans market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sartans ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sartans market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Valsartan; Telmisartan; Losartan; Irbesartan; Azilsartan; Olmesartan
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 3) By Application: Hypertension; Cardiovascular Diseases; Kidney Diseases; Other Applications
• 4) By End-User: Hospitals; Diagnostic Laboratories; Other End-Users
• Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sartans Market Characteristics

3. Sartans Market Trends And Strategies

4. Sartans Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sartans Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sartans PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sartans Market Growth Rate Analysis
• 5.4. Global Sartans Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sartans Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sartans Total Addressable Market (TAM)

6. Sartans Market Segmentation

• 6.1. Global Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Valsartan
• Telmisartan
• Losartan
• Irbesartan
• Azilsartan
• Olmesartan
• 6.2. Global Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.3. Global Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypertension
• Cardiovascular Diseases
• Kidney Diseases
• Other Applications
• 6.4. Global Sartans Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Other End-Users

7. Sartans Market Regional And Country Analysis

• 7.1. Global Sartans Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sartans Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sartans Market

• 8.1. Asia-Pacific Sartans Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sartans Market

• 9.1. China Sartans Market Overview
• 9.2. China Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sartans Market

• 10.1. India Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sartans Market

• 11.1. Japan Sartans Market Overview
• 11.2. Japan Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sartans Market

• 12.1. Australia Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sartans Market

• 13.1. Indonesia Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sartans Market

• 14.1. South Korea Sartans Market Overview
• 14.2. South Korea Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sartans Market

• 15.1. Western Europe Sartans Market Overview
• 15.2. Western Europe Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sartans Market

• 16.1. UK Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sartans Market

• 17.1. Germany Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sartans Market

• 18.1. France Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sartans Market

• 19.1. Italy Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sartans Market

• 20.1. Spain Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sartans Market

• 21.1. Eastern Europe Sartans Market Overview
• 21.2. Eastern Europe Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sartans Market

• 22.1. Russia Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sartans Market

• 23.1. North America Sartans Market Overview
• 23.2. North America Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sartans Market

• 24.1. USA Sartans Market Overview
• 24.2. USA Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sartans Market

• 25.1. Canada Sartans Market Overview
• 25.2. Canada Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sartans Market

• 26.1. South America Sartans Market Overview
• 26.2. South America Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sartans Market

• 27.1. Brazil Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sartans Market

• 28.1. Middle East Sartans Market Overview
• 28.2. Middle East Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sartans Market

• 29.1. Africa Sartans Market Overview
• 29.2. Africa Sartans Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sartans Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sartans Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sartans Market Competitive Landscape And Company Profiles

• 30.1. Sartans Market Competitive Landscape
• 30.2. Sartans Market Company Profiles
  • 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sartans Market Other Major And Innovative Companies

• 31.1. Aurobindo Pharma Ltd.
• 31.2. Dr. Reddy's Laboratories Ltd.
• 31.3. Cipla Ltd.
• 31.4. Cadila Pharmaceuticals Ltd.
• 31.5. Lupin Ltd.
• 31.6. Zydus Lifesciences Ltd.
• 31.7. Torrent Pharmaceuticals Ltd.
• 31.8. Alembic Pharmaceuticals Ltd.
• 31.9. Vasudha Pharma Chem Ltd.
• 31.10. Unichem Laboratories Ltd.
• 31.11. Global Pharma Tek
• 31.12. Manus Aktteva Biopharma LLP
• 31.13. Emcure Pharmaceuticals Ltd.
• 31.14. Wellona Pharma
• 31.15. JPM Pharma & Chemicals Pvt. Ltd.

32. Global Sartans Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sartans Market

34. Recent Developments In The Sartans Market

35. Sartans Market High Potential Countries, Segments and Strategies

• 35.1 Sartans Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sartans Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sartans Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer